Scandion Oncology

Scandion Oncology

Denmark - Copenhagen
Biotechnology

Focus: R&D/clinical trials treatment of chemotherapy resistance

Scandion Oncology is a life sciences company focused on R&D/clinical trials treatment of chemotherapy resistance.

OncologyNeurology
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

Phase 1/2
Clinical Trials (1)
NCT04247256A Phase 2 Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI
Phase 1/2
Clinical Trials (1)
NCT04652206Clinical Trial to Investigate Safety, Tolerability and MTD for SCO-101 in Combination With Gemcitabine and Nab-paclitaxel in Inoperable Pancreatic Cancer Patients.
Phase 1/2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 2 clinical trials